BioCardia, Inc.
BCDA
$1.39
-$0.06-4.14%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
GuruFocus
12/1/2025
-
Globe Newswire
11/24/2025
-
GuruFocus
11/24/2025
-
The Fly
11/24/2025
-
Globe Newswire
11/17/2025
-
GuruFocus
11/13/2025
-
Nasdaq News: Markets
11/13/2025
-
Fool.com Headlines
11/13/2025
-
TipRanks Financial Blog
11/13/2025
-
Seeking Alpha: Transcripts
11/13/2025
-
SeekingAlpha
11/13/2025
-
Nasdaq News: Markets
11/12/2025
-
GuruFocus
11/12/2025
-
Globe Newswire
11/11/2025
-
Benzinga
11/10/2025
-
GuruFocus
11/10/2025
-
GuruFocus
11/10/2025
-
TipRanks Financial Blog
11/10/2025
-
The Fly
11/10/2025
-
Globe Newswire
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/4/2025
-
Ticker Report
10/30/2025
-
GuruFocus
10/30/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 226 0120
Address
320 Soquel Way
Sunnyvale, CA 94085
Sunnyvale, CA 94085
Country
Year Founded
--
Business Description
Sector
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company’s lead...
more